PRINT

Current Research Studies

If you are interested in participating in any of the clinical research studies listed below, please call (734) 677-6000, option 4 to speak with a Research Associate (available Monday-Friday, 8:00am-5:00pm) or complete a Research Study Application form and someone from our Research Department will contact you within 48 hours.

Clinical Trials Now Enrolling

Acute Back Pain Study

Principal Investigator Dr. Shathabish Kariyanna is currently seeking volunteers to participate in a clinical research study to evaluate a new, non-opioid, investigational medication for patients suffering from back pain due to or associated with muscle spasms.

Kids Migraine Prevention Study (6-11 years old)

Principal Investigator Dr. Joel Saper is conducting a research study in Ann Arbor evaluating if an investigational migraine preventative medication is effective in reducing the number of migraines in children ages 6-11.

Acute Migraine Treatment Study

Dr. Joel Saper is recruiting adults who experience 2-8 migraine days a month to participate in a clinical trial investigating if an acute migraine medication is effective in reducing the amount of pain experienced during a single migraine attack.

Chronic Migraine Prevention Study

Dr. Joel Saper is recruiting adults who experience greater than 15 migraine days a month to participate in a clinical research trial for the preventative treatment of migraine.

Fibromyalgia Research Study

Dr. Shathabish Kariyanna is conducting a research study to evaluate if an investigational medication can help in reducing pain and symptoms associated with fibromyalgia in adults.

Kids/Teens Chronic Migraine Prevention Research Study

Dr. Joel Saper is conducting a research study in Ann Arbor evaluating if an investigational migraine preventative medication is effective in reducing the number of migraines in children ages 6-17 experiencing Chronic Migraine (greater than 15 migraine days per month).

Kids/Teens Episodic Migraine Prevention Research Study

Dr. Joel Saper is conducting a research study evaluating if an investigational migraine preventative medication is effective in reducing the number of migraines in children ages 6-17 experiencing Episodic Migraine (less than 15 migraine days per month).